CD4 and colitis: These studies could show that immunoproteasome inhibition reduces CD4+ IFN-γ+ Th1 and CD4+ IL-17+ Th17 cells in experimental autoimmune encephalomyelitis (12) and dextran sodium sulfate-induced colitis (9).